<DOC>
	<DOCNO>NCT00939614</DOCNO>
	<brief_summary>- Objective : - A randomized , open label , two treatment , two period , two sequence , single dose , crossover , bioequivalence study Lamotrigine 2 x 25mg IR tablet Torrent Pharmaceuticals Limited , India Lamictal ® ( Lamotrigine ) 2 x 25 mg tablet Glaxo-SmithKline , USA , healthy human adult subject , fast condition . - Study Design : - Randomized , open label , two treatment , two period , two sequence , single dose , crossover , 24+2 healthy human adult subject compare single dose bioavailability Torrent 's Lamotrigine Tablets 2 × 25 mg Lamictal® Tablets 2 × 25 mg GlaxoSmithKline . Dosing period separate washout period least 21 day .</brief_summary>
	<brief_title>Study Lamotrigine 2×25 mg IR Tablets Torrent Pharmaceuticals Limited , India Lamictal® ( Lamotrigine ) 2×25 mg Tablets GlaxoSmithKline , USA , Healthy Human Adult Subjects , Under Fasting Conditions .</brief_title>
	<detailed_description />
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Healthy adult subject either sex 1855 year age ( inclusive ) , body mass index ( BMI ) 18 27 kg/m2 . Subjects evidence underlie disease screen whose physical examination perform within 21 day prior commencement study . Subjects whose screen laboratory value within normal limit value outside normal limit consider physician/Principal Investigator clinical significance . Informed consent give write form accord section 11.3 protocol . Female Subjects : 1. child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . 2. postmenopausal least 1 year . 3. surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) . Cardiovascular , pulmonary , hepatic , renal , hematological , gastrointestinal , endocrine , immunologic , dermatologic , musculoskeletal , neurological psychiatric disease . Alcohol dependence , alcohol abuse drug abuse within past one year . Moderate heavy smoking ( &gt; 10 cigarettes/day ) consumption tobacco product . History difficulty swallow tablet . Clinically significant illness within 4 week start study Asthma , urticaria allergic type reaction take medication . Positive urine drug screening , HIV , Hepatitis B &amp; C test . Any history hypersensitivity Lamotrigine . Existence surgical medical condition , , judgment clinical investigator might interfere pharmacokinetics drug likely compromise safety subject . Inability communicate cooperate investigator due language problem , attitude , poor mental development/impaired cerebral function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>